Published in Curr Drug Metab on August 01, 2006
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer (2009) 2.26
Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models. PLoS One (2010) 1.27
Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood (2009) 1.21
Antioxidants, inflammation and cardiovascular disease. World J Cardiol (2014) 1.20
Breath analysis as a potential and non-invasive frontier in disease diagnosis: an overview. Metabolites (2015) 0.87
Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase. Free Radic Biol Med (2008) 0.85
Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance. Curr Neuropharmacol (2012) 0.83
Ovarian tumor-induced T cell suppression is alleviated by vascular leukocyte depletion. Transl Oncol (2009) 0.82
Therapeutic immunomodulation using a virus--the potential of inactivated orf virus. Eur J Clin Microbiol Infect Dis (2012) 0.81
Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance. Br J Cancer (2014) 0.80
Effect of human Wharton's jelly mesenchymal stem cell secretome on proliferation, apoptosis and drug resistance of lung cancer cells. Res Pharm Sci (2015) 0.78
Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells. Neoplasia (2008) 0.77
Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages. Int J Nanomedicine (2015) 0.76
A pooled multisite analysis of the effects of female reproductive hormones on glioma risk. Cancer Causes Control (2014) 0.76
Clinical significance of T-bet, GATA-3, and Bcl-6 transcription factor expression in bladder carcinoma. J Transl Med (2016) 0.76
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors. Onco Targets Ther (2017) 0.75
Carbon monoxide exposure may underlie the increased leukaemia risk in children living next to motor highways. Eur J Epidemiol (2015) 0.75
Influence of conjugated linoleic acid on the porcine immune response and morbidity: a randomized controlled trial. Lipids Health Dis (2009) 0.75
Inhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulation. Oncoimmunology (2016) 0.75
The predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer. Cancer Sci (2017) 0.75
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat Protoc (2008) 3.47
HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis (2010) 3.46
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood (2006) 2.58
Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta (2005) 2.29
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res (2006) 2.26
Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry (2011) 2.23
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl (2003) 2.04
Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2007) 2.00
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther (2010) 1.99
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis (2007) 1.92
More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem (2002) 1.89
Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet (2004) 1.80
Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol (2008) 1.69
Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg (2006) 1.66
Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation. Liver Transpl (2006) 1.60
The International Registry on Hand and Composite Tissue Transplantation. Transplantation (2010) 1.59
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis (2011) 1.59
Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem (2009) 1.57
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transplant (2005) 1.50
Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders. J Psychiatr Res (2013) 1.50
Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation (2002) 1.48
Urinary neopterin concentrations in patients with Balkan endemic nephropathy (BEN). Kidney Int (2003) 1.47
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 1.47
CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood (2006) 1.45
Proteomic profiling of acute cardiac allograft rejection. Transplantation (2009) 1.44
Estradiol enhances murine cardiac allograft rejection under cyclosporin and can be antagonized by the antiestrogen tamoxifen. Transplantation (2002) 1.44
[Soluble interleukin-2 and tumor necrosis factor receptor in liver cirrhosis. Relationship with clinical severity and prognosis]. Med Clin (Barc) (2004) 1.43
Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis (2013) 1.42
Tetrahydrobiopterin protects the kidney from ischemia-reperfusion injury. Kidney Int (2010) 1.41
The relationship between alcohol intake and cellular immune activity in systemic lupus erythematosus may change from inhibitory to stimulatory within 2 months of study: findings from an integrative single-case study. Clin Rheumatol (2009) 1.41
Enteroscopic biopsies in the management of pancreas transplants: a proof of concept study for a novel monitoring tool. Transplantation (2012) 1.40
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation (2005) 1.39
Single shot of alemtuzumab as induction therapy after kidney transplantation is sufficient. Transpl Int (2011) 1.39
The vascular nature of hemorrhoids. J Gastrointest Surg (2006) 1.38
Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem (2004) 1.37
Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection. Transplantation (2003) 1.35
The international registry on hand and composite tissue transplantation. Transplantation (2008) 1.35
Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood (2004) 1.34
Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. J Virol (2007) 1.32
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol (2009) 1.31
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Endocr Relat Cancer (2008) 1.30
Second report (1998-2006) of the International Registry of Hand and Composite Tissue Transplantation. Transpl Immunol (2007) 1.29
Neopterin, a prognostic marker in human malignancies. Cancer Lett (2009) 1.28
Neopterin production, tryptophan degradation, and mental depression--what is the link? Brain Behav Immun (2002) 1.28
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol (2004) 1.26
Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal (2007) 1.24
Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients. Dermatology (2007) 1.23
Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim Biophys Acta (2011) 1.22
Heterogeneity of mitochondria and mitochondrial function within cells as another level of mitochondrial complexity. Int J Mol Sci (2009) 1.22
Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques. J Immunol (2009) 1.21
Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood (2009) 1.21
Possible role of cytoskeleton in intracellular arrangement and regulation of mitochondria. Exp Physiol (2003) 1.19
Complete hepatic ischemia due to torsion of a large accessory liver lobe: first case to require transplantation. Transpl Int (2005) 1.19
Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion. Am J Physiol Heart Circ Physiol (2003) 1.18
Evaluation of mitochondrial respiratory function in small biopsies of liver. Anal Biochem (2002) 1.17
Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol (2005) 1.17
Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact? Anticancer Res (2004) 1.16
Revised morphology and hemodynamics of the anorectal vascular plexus: impact on the course of hemorrhoidal disease. Int J Colorectal Dis (2008) 1.15
14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin Cancer Res (2005) 1.15
Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy. J Acquir Immune Defic Syndr (2010) 1.15
Alveolar granulocyte colony-stimulating factor and alpha-chemokines in relation to serum levels, pulmonary neutrophilia, and severity of lung injury in ARDS. Chest (2004) 1.15
Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J Rheumatol (2003) 1.15
Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis (2011) 1.15
Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Clin Immunol (2002) 1.12
Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation (2006) 1.12
Early experience with robot-assisted surgery for mediastinal masses. Ann Thorac Surg (2004) 1.11
Subcellular heterogeneity of mitochondrial function and dysfunction: evidence obtained by confocal imaging. Mol Cell Biochem (2004) 1.11
Bilirubin and biliverdin treatment of atherosclerotic diseases. Cell Cycle (2007) 1.11
Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am J Transplant (2005) 1.11
The cell-type specificity of mitochondrial dynamics. Int J Biochem Cell Biol (2009) 1.11
Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. Curr Vasc Pharmacol (2006) 1.09
Prenatal depression and anxiety in Toxoplasma gondii-positive women. Am J Obstet Gynecol (2011) 1.08
Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege. J Immunol (2007) 1.08
Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy. Brain Behav Immun (2008) 1.08
Mitochondrial subpopulations and heterogeneity revealed by confocal imaging: possible physiological role? Biochim Biophys Acta (2006) 1.08
Neopterin in HIV-1 infection. Mol Immunol (2005) 1.08
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway. Am J Pathol (2003) 1.07
Results and complications after Swedish adjustable gastric banding-10 years experience. Obes Surg (2009) 1.07
Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer Lett (2006) 1.07
Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen. Scand J Infect Dis (2004) 1.06
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection. J Affect Disord (2007) 1.05
Monocyte-derived dendritic cells release neopterin. J Leukoc Biol (2002) 1.04
Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection. AIDS (2002) 1.04